Our areas of partnering interest 金沙官网app投注

金沙app

  • 金沙官网app投注


    金沙官网8331澳门
  • 金沙官网app投注


    金沙官网
  • 金沙官网app投注


    金沙官网9304

  • 金沙官网app投注


    金沙官网3983
  • 金沙官网app投注


    奥门金沙官网
  • 金沙官网app投注


    澳门金沙平台官网



金沙app

No matter where in the world you may be located, we are interested in exploring leading-edge collaboration opportunities with you – across our main therapy areas and beyond. We carefully consider local medical circumstances and adopt a flexible approach that enables us to meet specific patient needs in key markets.

In China, for example, we are exploring opportunities that support and enhance our existing commercial strength. Our focus is on partnering opportunities at or near commercial launch stage, in areas such as pediaetric, nebulised, pulmonary, gastric, cardiovascular, and traditional Chinese medicine. Our interest goes beyond pharmaceutical products to diagnostics, devices, and digital technologies. We aim to work with a range of partners to build end-to-end patient solutions that help improve disease awareness, diagnosis, treatment and post-treatment care. While these partnerships are designed to meet the unmet medical needs of local patients, some also have potential to benefit patients globally.

Using our presence and reach, we can also help you commercialise your product in China and other international markets.





金沙app


金沙官网app投注

金沙官网app投注

金沙官网app投注

金沙官网app投注

金沙官网app投注

金沙官网app投注


金沙官网app投注

金沙官网app投注

金沙官网app投注

金沙官网app投注


*Measured by value in the hospital sector (by sales)



Veeva ID: Z4-21503
Date of Prep: Dec 2019
Expiry Date: Dec 2020